We identified a novel carcinoma metabolism pathway involving the MCT-1-YY1-EGFR-MnSOD network, which confers oxidative resistance to oncogenic cells, accompanied by an enhancement in the tumor microenvironment and tumor progression. The gene discussed is SOD2; the disease is neoplasm.